Cargando…
A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease
The mosquito-borne chikungunya virus (CHIKV) has become a major global health problem. Upon infection, chikungunya fever (CHIKF) can result in long-term joint pain and arthritis, and despite intense research, no licensed vaccine for CHIKV is available. We have developed two recombinant chimpanzee ad...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963200/ https://www.ncbi.nlm.nih.gov/pubmed/31718104 http://dx.doi.org/10.3390/pathogens8040231 |
_version_ | 1783488231742898176 |
---|---|
author | Campos, Rafael Kroon Preciado-Llanes, Lorena Azar, Sasha R. Lopez-Camacho, Cesar Reyes-Sandoval, Arturo Rossi, Shannan L. |
author_facet | Campos, Rafael Kroon Preciado-Llanes, Lorena Azar, Sasha R. Lopez-Camacho, Cesar Reyes-Sandoval, Arturo Rossi, Shannan L. |
author_sort | Campos, Rafael Kroon |
collection | PubMed |
description | The mosquito-borne chikungunya virus (CHIKV) has become a major global health problem. Upon infection, chikungunya fever (CHIKF) can result in long-term joint pain and arthritis, and despite intense research, no licensed vaccine for CHIKV is available. We have developed two recombinant chimpanzee adenovirus-vectored vaccines (ChAdOx1) that induce swift and robust anti-CHIKV immune responses with a single dose, without the need for adjuvants or booster vaccines. Here, we report the vaccines’ protective efficacies against CHIKV infection in a lethal A129 mouse model. Our results indicate that a single, un-adjuvanted ChAdOx1 Chik or ChAdOx1 Chik ΔCap dose provided complete protection against a lethal virus challenge and prevented CHIKV-associated severe inflammation. These candidate vaccines supported survival equal to the attenuated 181/25 CHIKV reference vaccine but without the vaccine-related side effects, such as weight loss. Vaccination with either ChAdOx1 Chik or ChAdOx1 Chik ΔCap resulted in high titers of neutralizing antibodies that are associated with protection, indicating that the presence of the capsid within the vaccine construct may not be essential to afford protection under the conditions tested. We conclude that both replication-deficient ChAdOx1 Chik vaccines are safe even when used in A129 mice and afford complete protection from a lethal challenge. |
format | Online Article Text |
id | pubmed-6963200 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-69632002020-01-27 A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease Campos, Rafael Kroon Preciado-Llanes, Lorena Azar, Sasha R. Lopez-Camacho, Cesar Reyes-Sandoval, Arturo Rossi, Shannan L. Pathogens Article The mosquito-borne chikungunya virus (CHIKV) has become a major global health problem. Upon infection, chikungunya fever (CHIKF) can result in long-term joint pain and arthritis, and despite intense research, no licensed vaccine for CHIKV is available. We have developed two recombinant chimpanzee adenovirus-vectored vaccines (ChAdOx1) that induce swift and robust anti-CHIKV immune responses with a single dose, without the need for adjuvants or booster vaccines. Here, we report the vaccines’ protective efficacies against CHIKV infection in a lethal A129 mouse model. Our results indicate that a single, un-adjuvanted ChAdOx1 Chik or ChAdOx1 Chik ΔCap dose provided complete protection against a lethal virus challenge and prevented CHIKV-associated severe inflammation. These candidate vaccines supported survival equal to the attenuated 181/25 CHIKV reference vaccine but without the vaccine-related side effects, such as weight loss. Vaccination with either ChAdOx1 Chik or ChAdOx1 Chik ΔCap resulted in high titers of neutralizing antibodies that are associated with protection, indicating that the presence of the capsid within the vaccine construct may not be essential to afford protection under the conditions tested. We conclude that both replication-deficient ChAdOx1 Chik vaccines are safe even when used in A129 mice and afford complete protection from a lethal challenge. MDPI 2019-11-12 /pmc/articles/PMC6963200/ /pubmed/31718104 http://dx.doi.org/10.3390/pathogens8040231 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Campos, Rafael Kroon Preciado-Llanes, Lorena Azar, Sasha R. Lopez-Camacho, Cesar Reyes-Sandoval, Arturo Rossi, Shannan L. A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title | A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title_full | A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title_fullStr | A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title_full_unstemmed | A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title_short | A Single and Un-Adjuvanted Dose of a Chimpanzee Adenovirus-Vectored Vaccine against Chikungunya Virus Fully Protects Mice from Lethal Disease |
title_sort | single and un-adjuvanted dose of a chimpanzee adenovirus-vectored vaccine against chikungunya virus fully protects mice from lethal disease |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963200/ https://www.ncbi.nlm.nih.gov/pubmed/31718104 http://dx.doi.org/10.3390/pathogens8040231 |
work_keys_str_mv | AT camposrafaelkroon asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT preciadollaneslorena asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT azarsashar asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT lopezcamachocesar asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT reyessandovalarturo asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT rossishannanl asingleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT camposrafaelkroon singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT preciadollaneslorena singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT azarsashar singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT lopezcamachocesar singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT reyessandovalarturo singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease AT rossishannanl singleandunadjuvanteddoseofachimpanzeeadenovirusvectoredvaccineagainstchikungunyavirusfullyprotectsmicefromlethaldisease |